These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21439060)

  • 21. Development of a micro-neutralization assay for ebolaviruses using a replication-competent vesicular stomatitis hybrid virus and a quantitative PCR readout.
    Lee SS; Phy K; Peden K; Sheng-Fowler L
    Vaccine; 2017 Oct; 35(41):5481-5486. PubMed ID: 28427845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A poxvirus of primates. II. Immunology.
    Nicholas AH
    J Natl Cancer Inst; 1970 Nov; 45(5):907-14. PubMed ID: 18605416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a tissue-culture-based enzyme-immunoassay method for the quantitation of anti-vaccinia-neutralizing antibodies in human sera.
    Eyal O; Olshevsky U; Lustig S; Paran N; Halevy M; Schneider P; Zomber G; Fuchs P
    J Virol Methods; 2005 Dec; 130(1-2):15-21. PubMed ID: 16024096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring of human immunological responses to vaccinia virus.
    Harrop R; Ryan MG; Golding H; Redchenko I; Carroll MW
    Methods Mol Biol; 2004; 269():243-66. PubMed ID: 15114020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
    Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
    Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response of dairy calves to vaccinia viruses that express foreign genes.
    Gillespie JH; Geissinger C; Scott FW; Higgins WP; Holmes DF; Perkus M; Mercer S; Paoletti E
    J Clin Microbiol; 1986 Feb; 23(2):283-8. PubMed ID: 3700615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccinia virus infection in monkeys, Brazilian Amazon.
    Abrahão JS; Silva-Fernandes AT; Lima LS; Campos RK; Guedes MI; Cota MM; Assis FL; Borges IA; Souza-Júnior MF; Lobato ZI; Bonjardim CA; Ferreira PC; Trindade GS; Kroon EG
    Emerg Infect Dis; 2010 Jun; 16(6):976-9. PubMed ID: 20507750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a rapid image-based high-content imaging screening assay to evaluate therapeutic antibodies against the monkeypox virus.
    Kota KP; Ziółkowska NE; Wei J; Peng J; Ordonez D; Raney C; Prigge J; Hooper JW; Awasthi M; Goebel SJ; Zabel BA; Nasar F; Lederman S; Bavari S
    Antiviral Res; 2023 Feb; 210():105513. PubMed ID: 36592670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine.
    Newman FK; Frey SE; Blevins TP; Mandava M; Bonifacio A; Yan L; Belshe RB
    J Clin Microbiol; 2003 Jul; 41(7):3154-7. PubMed ID: 12843056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunity.
    He Y; Manischewitz J; Meseda CA; Merchlinsky M; Vassell RA; Sirota L; Berkower I; Golding H; Weiss CD
    J Infect Dis; 2007 Oct; 196(7):1026-32. PubMed ID: 17763325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Humoral and cellular immunity against both ZIKV and poxvirus is elicited by a two-dose regimen using DNA and non-replicating vaccinia virus-based vaccine candidates.
    Zhan Y; Deng Y; Huang B; Song Q; Wang W; Yang Y; Dai L; Wang W; Yan J; Gao GF; Tan W
    Vaccine; 2019 Apr; 37(15):2122-2130. PubMed ID: 30851967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of a national network of validated and qualified laboratories for neutralizing anti-vaccinia antibodies titration.
    Poirier B; Leparc-Goffart I; Crance JM; Fleury H; Garin D; Gut JP; Tissier MH; Fuchs F
    Biologicals; 2005 Dec; 33(4):277-82. PubMed ID: 16181788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examination of the cross-reactivity between vaccinia virus Tiantan strain and monkeypox virus.
    Huang Q; Wang Y; Zhao T; Wang Y; Wang X; Li S; Su W; Ren X; Zhang X; Liu J; Wei J
    J Virol Methods; 2023 Oct; 320():114772. PubMed ID: 37473582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant modified vaccinia virus ankara expressing the surface gp120 of simian immunodeficiency virus (SIV) primes for a rapid neutralizing antibody response to SIV infection in macaques.
    Ourmanov I; Bilska M; Hirsch VM; Montefiori DC
    J Virol; 2000 Mar; 74(6):2960-5. PubMed ID: 10684319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [An unusual infection with the vaccinia virus (poxvirus officinale)].
    Kirsch WD; Handrick W; Keller HP
    Dtsch Med Wochenschr; 1973 Jun; 98(26):1292-4. PubMed ID: 4714029
    [No Abstract]   [Full Text] [Related]  

  • 36. Linear Epitopes in Vaccinia Virus A27 Are Targets of Protective Antibodies Induced by Vaccination against Smallpox.
    Kaever T; Matho MH; Meng X; Crickard L; Schlossman A; Xiang Y; Crotty S; Peters B; Zajonc DM
    J Virol; 2016 May; 90(9):4334-4345. PubMed ID: 26889021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of antibodies to orthopoxviruses in human sera by radioimmunoassay.
    Walls HH; Ziegler DW; Nakano JH
    Bull World Health Organ; 1981; 59(2):253-62. PubMed ID: 6265114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zoonotic vaccinia virus infection in Brazil: clinical description and implications for health professionals.
    de Souza Trindade G; Drumond BP; Guedes MI; Leite JA; Mota BE; Campos MA; da Fonseca FG; Nogueira ML; Lobato ZI; Bonjardim CA; Ferreira PC; Kroon EG
    J Clin Microbiol; 2007 Apr; 45(4):1370-2. PubMed ID: 17287326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A tetrazolium-based colorimetric assay for titration of neutralizing antibodies against vaccinia virus.
    Ifrah M; Stienlauf S; Shoresh M; Katz E
    Viral Immunol; 1998; 11(1):49-54. PubMed ID: 9586697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune response to vaccinia virus and recombinant virus products in dogs.
    Appel MJ; Paoletti E
    Am J Vet Res; 1988 Nov; 49(11):1932-4. PubMed ID: 2977718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.